Publications

Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

Lin G-L. et al, (2024), Nature Communications, 15

Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

Wei J. et al, (2024), Nature Communications, 15

Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study.

Hall M. et al, (2023), The Lancet. Microbe

Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.

Monod M. et al, (2023), Nature microbiology

Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes.

Christensen KT. et al, (2023), Viruses, 15

Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.

Jenkins F. et al, (2023), Journal of medical virology, 95

Correction: Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.

Fryer HR. et al, (2023), PLoS pathogens, 19

Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey.

Lythgoe KA. et al, (2023), Proceedings. Biological sciences, 290

Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.

Abdullahi A. et al, (2023), The Journal of antimicrobial chemotherapy, 78, 2000 - 2007

Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.

Fryer HR. et al, (2023), PLoS pathogens, 19

COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK

Buckell J. et al, (2023), Scientific Reports, 13

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK

Wei J. et al, (2023), Nature Communications, 14

Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

Cotton S. et al, (2023), Journal of Hospital Infection, 135, 28 - 36

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

Kläser K. et al, (2022), Scientific Reports, 12

Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

Nickbakhsh S. et al, (2022), Scientific Reports, 12

The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA

Zhao L. et al, (2022), Proceedings of the Royal Society B: Biological Sciences, 289

Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Willett BJ. et al, (2022), Nature Microbiology, 7, 1709 - 1709

Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort.

Christensen KT. et al, (2022), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 155

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom

Vihta1 KD. et al, (2022), Clinical Infectious Diseases

SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.

Eales O. et al, (2022), BMC infectious diseases, 22

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Willett BJ. et al, (2022), Nature Microbiology, 7, 1161 - 1179

Recurrent SARS-CoV-2 mutations in immunodeficient patients.

Wilkinson SAJ. et al, (2022), Virus evolution, 8

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection

Wei J. et al, (2022), Nature Communications, 13

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Wei J. et al, (2022), Nature Medicine

Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.

Aggarwal D. et al, (2022), Nature communications, 13

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei J. et al, (2021)

Cookies on this website

Publications